Nantahala Capital Management, LLC Eton Pharmaceuticals, Inc. Transaction History
Nantahala Capital Management, LLC
- $2.29 Billion
- Q2 2025
A detailed history of Nantahala Capital Management, LLC transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Nantahala Capital Management, LLC holds 1,175,951 shares of ETON stock, worth $20.4 Million. This represents 0.73% of its overall portfolio holdings.
Number of Shares
1,175,951
Previous 1,175,951
-0.0%
Holding current value
$20.4 Million
Previous $15.3 Million
9.79%
% of portfolio
0.73%
Previous 0.69%
Shares
4 transactions
Others Institutions Holding ETON
# of Institutions
85Shares Held
15MCall Options Held
242KPut Options Held
11.8K-
Opaleye Management Inc. Boston, MA2.86MShares$49.5 Million9.75% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA2.03MShares$35.2 Million2.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.31MShares$22.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA593KShares$10.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY510KShares$8.83 Million0.0% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $438M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...